                               SEQUENCE LISTING

<110> UNIVERSITY OF IOWA RESEARCH FOUNDATION
 
<120> IMMUNOTHERAPY OF LEISHMANIASIS

<130> 17023.221WO1

<140> PCT/US2019/017872
<141> 2019-02-13

<150> 62/630,053
<151> 2018-02-13

<160> 10     

<170> PatentIn version 3.5

<210> 1
<211> 6
<212> PRT
<213> Leishmania sp.

<400> 1
Gly Pro Leu Ser Val Gly 
1               5       


<210> 2
<211> 10
<212> PRT
<213> Leishmania sp.

<400> 2
Pro Leu Ser Val Gly Pro Gln Ser Val Gly 
1               5                   10  


<210> 3
<211> 119
<212> PRT
<213> Leishmania sp.

<400> 3
Met Lys Ile Arg Ser Val Arg Pro Leu Val Val Leu Leu Val Cys Val 
1               5                   10                  15      


Ala Ala Val Leu Ala Leu Ser Ala Ser Ala Glu Pro His Lys Ala Ala 
            20                  25                  30          


Val Asp Ala Gly Pro Leu Ser Val Asp Val Gly Pro Leu Ser Val Asp 
        35                  40                  45              


Val Gly Pro Leu Ser Val Gly Pro Gln Ser Val Gly Pro Leu Ser Val 
    50                  55                  60                  


Gly Pro Gln Ser Val Asp Pro Leu Ser Val Asp Val Gly Pro Leu Ser 
65                  70                  75                  80  


Val Gly Pro Gln Ser Val Gly Pro Leu Ser Val Asp Val Gly Pro Leu 
                85                  90                  95      


Ser Val Gly Pro Gln Ser Val Gly Pro Leu Ser Val Gly Leu Gln Ala 
            100                 105                 110         


Val Asp Val Ser Pro Val Ser 
        115                 


<210> 4
<211> 102
<212> PRT
<213> Leishmania sp.

<400> 4
Met Lys Ile Arg Ser Val Arg Pro Leu Val Val Leu Leu Val Cys Val 
1               5                   10                  15      


Ala Ala Val Leu Ala Leu Ser Ala Ser Ala Glu Pro His Lys Ala Ala 
            20                  25                  30          


Val Asp Val Gly Pro Leu Ser Val Asp Val Gly Pro Leu Ser Val Asp 
        35                  40                  45              


Val Gly Pro Leu Ser Val Gly Pro Gln Ser Val Gly Pro Leu Ser Val 
    50                  55                  60                  


Gly Pro Gln Ser Val Gly Pro Leu Ser Val Asp Val Gly Pro Leu Ser 
65                  70                  75                  80  


Val Gly Pro Gln Ser Val Gly Pro Leu Ser Val Gly Pro Gln Ser Val 
                85                  90                  95      


Asp Val Ser Pro Val Ala 
            100         


<210> 5
<211> 88
<212> PRT
<213> Leishmania sp.

<400> 5
Met Lys Ile Arg Ser Val Arg Pro Leu Val Val Leu Leu Val Cys Val 
1               5                   10                  15      


Ala Ala Val Leu Ala Leu Ser Ala Ser Ala Glu Pro His Lys Ala Ala 
            20                  25                  30          


Val Asp Val Gly Pro Leu Ser Val Asp Val Gly Pro Leu Ser Val Gly 
        35                  40                  45              


Pro Gln Ser Val Gly Pro Leu Ser Val Gly Pro Gln Ala Val Gly Pro 
    50                  55                  60                  


Leu Ser Val Gly Pro Gln Ser Val Gly Pro Leu Ser Val Gly Leu Gln 
65                  70                  75                  80  


Ala Val Asp Val Ser Pro Val Ser 
                85              


<210> 6
<211> 113
<212> PRT
<213> Leishmania sp.

<400> 6
Met Lys Ile Arg Ser Val Arg Pro Leu Val Val Leu Leu Val Cys Val 
1               5                   10                  15      


Ala Ala Val Leu Ala Leu Ser Ala Ser Ala Glu Pro His Lys Ala Ala 
            20                  25                  30          


Val Asp Val Gly Pro Leu Ser Val Asp Val Gly Pro Leu Ser Val Gly 
        35                  40                  45              


Pro Gln Ser Val Gly Pro Leu Ser Val Gly Pro Leu Ser Val Gly Pro 
    50                  55                  60                  


Gln Ala Val Gly Pro Leu Ser Val Gly Pro Gln Ala Val Gly Leu Leu 
65                  70                  75                  80  


Ser Val Gly Pro Gln Ser Val Gly Pro Leu Ser Val Gly Pro Gln Ser 
                85                  90                  95      


Val Gly Pro Leu Ser Val Gly Leu Gln Ala Val Asp Val Ser Pro Val 
            100                 105                 110         


Ser 
    


<210> 7
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 7
aagtgctttc ccatcgcaac t                                                 21


<210> 8
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 8
cgcactaaac ccctccaa                                                     18


<210> 9
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      probe

<400> 9
cggttcggtg tgtggcgcc                                                    19


<210> 10
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      6xHis tag

<400> 10
His His His His His His 
1               5       

